Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Zero based budgeting yields tangible outcomes compared to traditional budgeting, including tighter control and clearer allocation of resources.
22,247 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Tech stocks lead an early market rebound as progress in Middle East talks eases risk concerns. The Nasdaq Composite m...
When a founder dumps stock, investors naturally pause. This article explains what the Lindblad Expeditions sell after...
Signet Jewelers stock just moved higher as the company rolls out a growth strategy focused on core brands and smarter...
Lucid Diagnostics (LUCD) is navigating reimbursement and adoption as it scales its non-invasive tests. This analysis ...
A $50,000 investment can feel like a fork in the road. This guide explains why Amazon stock still has the potential t...
Craving AI gains but wary of pitfalls? This guide shows how to diversify portfolio 2026 by steering clear of two risk...
Nordson (NDSN) is set for a pivotal 2025 earnings year. This guide breaks down the levers that could move profits, ho...
Want lasting portfolio growth? Explore three brilliant growth stocks hold for the long term, including Nvidia, Micros...
Five Below is navigating a evolving bargain-hunting landscape in 2026. This article breaks down a hypothetical Q1 202...
A director sold 3,000 BlackLine shares in an open-market move. Here’s how to interpret that action, what it says abou...
Investors dig into a mixed session as Amazon leads gains on Prime Day momentum and AI shopping activity. This guide b...